Enuresis Clinical Trial
Official title:
Family Help Program: Primary Care Delivery by Telephone for Psychological and Behavioural Problems (Pediatric Enuresis)
The purpose of the Strongest Families (formerly Family Help Program)is to evaluate the effectiveness of the Strongest Families distance intervention compared to usual or standard care that is typically provided to children with mild to moderate Enuresis diagnoses. This is a single-centre trial based at the IWK Health Centre. The primary outcome is change in diagnosis.
The purpose of the Family Help Program is to deliver, primary care mental health services to
children and their families in the comfort and privacy of their own home. Approximately 46
children (5-12 years of age)suffering from pediatric enuresis (at least 2 times a week) will
be randomized.
The intervention is delivered from a distance, using the urine alarm system accompanied by
educational materials (manuals, video-tapes, audio-tapes) and telephone consultation with a
trained paraprofessional "coach" who is supervised by a licensed health care professional.
The telephone coach delivers consistent care based on written protocols, with on-going
evaluation by a professional team.
Fifty percent of the eligible participants will receive Family Help Program telephone-based
treatment and 50% will be referred back to their family physician to receive standard care
as determined by that physician. Those receiving standard care will be evaluated for outcome
results and then compared to the Family Help treated participants. It is anticipated that
Family Help treatment will be proven to be as or more effective than standard care.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02600676 -
Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis
|
N/A | |
Completed |
NCT02369445 -
Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention
|
N/A | |
Completed |
NCT01978210 -
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
|
N/A | |
Recruiting |
NCT06070675 -
Comparison of a Paper and Automated Bladder Diary in Pediatric Patients
|
N/A | |
Completed |
NCT01747343 -
Toilet Training Toddlers and Preschoolers
|
N/A | |
Recruiting |
NCT00437528 -
Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity
|
Phase 1 | |
Recruiting |
NCT02699528 -
The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Withdrawn |
NCT01861145 -
Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea
|
Phase 4 | |
Completed |
NCT04260646 -
Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children
|
N/A | |
Completed |
NCT01367080 -
A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg
|
Phase 1 | |
Completed |
NCT00226122 -
The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal
|
Phase 4 | |
Completed |
NCT05190601 -
Uroflowmetry in Children With Enuresis Nocturnal
|
||
Withdrawn |
NCT03478813 -
Voiding School as a Treatment of Children's Day-time Incontinence or Enuresis
|
N/A | |
Recruiting |
NCT03399877 -
A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography
|
N/A | |
Completed |
NCT01036841 -
Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation
|
Phase 4 | |
Active, not recruiting |
NCT06185361 -
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
|
N/A | |
Completed |
NCT04280887 -
MyPad - Intelligent Bladder Pre-void Alerting System
|
N/A | |
Completed |
NCT00240812 -
A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting
|
Phase 2 |